Analyses of the correlation between SREBF2-AS1 expression level and clinicopathological characteristics of HCC patients based on TCGA LIHC dataset showed that high expression of SREBF2-AS1 was positively correlated with high alpha-fetoprotein (AFP) concentration and advanced stage (Table 1). Here, SREBF2 is linked to hepatocellular carcinoma.